Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes

Total Page:16

File Type:pdf, Size:1020Kb

Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes Published OnlineFirst June 4, 2014; DOI: 10.1158/1078-0432.CCR-13-3036 Clinical Cancer Biology of Human Tumors Research Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes Gabriel G. Malouf1, Xiaoping Su7, Hui Yao7, Jianjun Gao8, Liangwen Xiong8, Qiuming He8, Eva Comperat 2, Jer ome^ Couturier3, Vincent Molinie4, Bernard Escudier5, Philippe Camparo6, Denaha J. Doss9, Erika J. Thompson9, David Khayat1, Christopher G. Wood10, Willie Yu11, Bin T. Teh11, John Weinstein7, and Nizar M. Tannir8 Abstract Purpose: MITF/TFE translocation renal cell carcinoma (TRCC) is a rare subtype of kidney cancer. Its incidence and the genome-wide characterization of its genetic origin have not been fully elucidated. Experimental Design: We performed RNA and exome sequencing on an exploratory set of TRCC (n ¼ 7), and validated our findings using The Cancer Genome Atlas (TCGA) clear-cell RCC (ccRCC) dataset (n ¼ 460). Results: Using the TCGA dataset, we identified seven TRCC (1.5%) cases and determined their genomic profile. We discovered three novel partners of MITF/TFE (LUC7L3, KHSRP, and KHDRBS2) that are involved in RNA splicing. TRCC displayed a unique gene expression signature as compared with other RCC types, and showed activation of MITF, the transforming growth factor b1 and the PI3K complex targets. Genes differentially spliced between TRCC and other RCC types were enriched for MITF and ID2 targets. Exome sequencing of TRCC revealed a distinct mutational spectrum as compared with ccRCC, with frequent mutations in chromatin-remodeling genes (six of eight cases, three of which were from the TCGA). In two cases, we identified mutations in INO80D, an ATP-dependent chromatin-remodeling gene, previously shown to control the amplitude of the S phase. Knockdown of INO80D decreased cell proliferation in a novel cell line bearing LUC7L3–TFE3 translocation. Conclusions: This genome-wide study defines the incidence of TRCC within a ccRCC-directed project and expands the genomic spectrum of TRCC by identifying novel MITF/TFE partners involved in RNA splicing and frequent mutations in chromatin-remodeling genes. Clin Cancer Res; 20(15); 1– 12. Ó2014 AACR. Introduction Authors' Affiliations: Departments of 1Medical Oncology and 2Pathology, Groupe Hospitalier Pitie-Salp etri^ ere, Assistance Publique Hopitaux de Translocation renal cell carcinoma (TRCC) is a rare Paris, Faculty of Medicine Pierre et Marie Curie, Institut Universitaire de Cancerologie GRC5, University Paris 6; 3Department of Genetics, Institut subtype of kidney cancer that was added to the World Curie; 4Department of Pathology, Hopital^ Saint Joseph, Paris; 5Department Health Organization (WHO) classification in 2004 (1) and of Medical Oncology, Institut Gustave Roussy, Villejuif; 6Centre de Patho- is histologically and genomically a heterogeneous disease logie, Amiens, Picardie, France; Departments of 7Bioinformatics and Computational Biology and 8Genitourinary Medical Oncology, 9DNA Anal- (2, 3). TRCC is characterized by translocations involving the ysis Facility, Department of Genetics, 10Division of Surgery, Department of genes for transcription factors E3 (TFE3) and EB (TFEB; Urology, The University of Texas MD Anderson Cancer Center, Houston, refs. 1–4). TFE3 and TFEB belong to the microphthalmia Texas; and 11Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore transcription factor/transcription factor E (MITF/TFE) fam- Note: Supplementary data for this article are available at Clinical Cancer ily of basic helix-loop-helix leucine zipper (bHLH-LZ), and Research Online (http://clincancerres.aacrjournals.org/). are often called MITF TRCC. Although the TFEB gene has been reported to fuse exclusively with the Alpha gene, G.G. Malouf, X. Su, and H. Yao contributed equally to the work and share the role of first author as first coauthors. leading to t(6;11)(p21;q21) translocation, the TFE3 gene Corresponding Authors: Nizar M. Tannir, University of Texas MD Ander- (Xp11.2) has been found to rearrange with at least five son Cancer Center, 1155 Pressler Street, Unit 1374, Houston, TX 77030- different partners: PRCC (1q21), ASPSCR1 (17q25), SFPQ 3721. Phone: 713-563-7265; Fax: 713-745-0422; E-mail: (1p34), NONO (Xq12), and CLTC (17q23; refs. 1–6). The [email protected]; and Gabriel G. Malouf, Department of Medical Oncology, Hopital^ de la Pitie-salp etriere,^ 43, Boulevard de l'Hopital,^ 75013, breakpoints of those translocations differ according to the Paris, France. Phone: þ33 1 42 16 04 61; Fax: þ33142160423; TFE3 partner, and all TFE3 fusion proteins contain the [email protected] bHLH-LZ and transcriptional activation domains of TFE3 doi: 10.1158/1078-0432.CCR-13-3036 (7). Unlike TFE3, the TFEB gene rearranges with Alpha,an Ó2014 American Association for Cancer Research. intronless gene, leading to a translocation that preserves the www.aacrjournals.org OF1 Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst June 4, 2014; DOI: 10.1158/1078-0432.CCR-13-3036 Malouf et al. Cancer Center (MDACC) and Institut Curie, fresh tissue Translational Relevance specimens were obtained at the time of nephrectomy and We performed exome and RNA sequencing on seven stored at À80C until DNA and RNA extraction were MITF/TFE translocation renal cell carcinoma (TRCC) carried out. The clinicopathologic characteristics of these tumors and validated our findings in seven of 460 cases are summarized in Supplementary Table S1. Geno- (1.5%) clear-cell RCC cases from The Cancer Genome mic DNA with matched normal DNA (adjacent normal Atlas (TCGA). We discovered three novel partners of kidney tissue) was available from three cases (Supple- MITF/TFE (LUC7L3, KHSRP, and KHDRBS2) that are mentary Table S1). RNA from seven controls (three pap- involved in RNA splicing. TRCC displayed a unique gene illary RCC, one ccRCC, and three normal kidney samples) expression signature with activation of MITF, the trans- was included. RNA was available for seven cases (Sup- forming growth factor b1, and the PI3K complexes. plementary Table S1). DNA extraction was performed Genes differentially spliced between TRCC and using the DNeasy Blood & Tissue Kit (Qiagen) according other RCC types were enriched for MITF targets, sug- to the manufacturer’s instructions. RNA extraction was gesting a putative role for RNA splicing in kidney performed using the RNeasy Kit (Qiagen) according to carcinogenesis. Exome sequencing revealed mutations the manufacturer’s instructions. in the chromatin-remodeling gene INO80D.Ourstudy expands the spectrum of TRCC and raises potential RNA sequencing therapeutic implications. Total RNA for each sample was converted into a library of template molecules for sequencing on the Illumina HiSeq 2000 according to the NuGen Ovation RNA-Seq System V2 protocol. The details are reported in Supplementary Mate- TFEB full-length coding region, which becomes dysregu- rials and Methods. lated by the Alpha gene promoter (8). TRCC represents 15% of RCC in patients younger than Mapping/alignment 40 years (9, 10). The incidence of TRCC varies between 1% We checked the quality of the sequencing data by using and 6% according to previously published studies, several HTSeq package. The raw paired-end reads in FASTQ format TFE3 of which used morphology and expression alone to were then aligned to the human reference genome, screen for RCC cases with translocation (10–12). However, GRCh37/hg19, using MOSAIK alignment software (20). the true incidence of TRCC in an unselected cohort of MOSAIK works with paired-end reads from Illumina HiSeq pathologically confirmed clear-cell RCC (ccRCC) remains 2000 and uses both a hashing scheme and the Smith– to be determined. Next-generation sequencing highly Waterman algorithm to produce gapped optimal align- improved our understanding of ccRCC, known to bear ments and to map exon junction-spanning reads with a inactivation of the von Hippel-Lindau (VHL) tumor-sup- local alignment option for RNA-Seq. The resulting pair-wise pressor gene, located on chromosome 3p arm (13). Large- alignments were then consolidated into a multiple scale screening has identified several new cancer genes that sequence alignment (assembly) and saved as a standard PBRM1 include mutations in the SWI/SNF family gene (14) bam file. and BAP1 (15), as well as mutations in chromatin remo- KDM6A KDM5C SETD2 ( ) delers such as (16), , and 17 .To Identification of differentially expressed genes from date, the genetic basis and origins of TRCC remain poorly RNA-Seq understood on a genome-wide scale. The details are presented in Supplementary Materials and Compared with ccRCC, which displays gene expression Methods. profiles composed of two main transcriptomic subsets named ccA and ccB (18), the transcriptomic signature of Fusion detection from RNA-Seq TRCC remains obscure. Although in a previous study A modified version of VirusSeq that implements a MITF/TFE tumors of the family were shown to display a greedy algorithm with a robust statistical model was unique gene expression signature (19), their full transcrip- implemented and used in gene fusion discovery for tomic signature remains unknown. RNA-Seq data (21). The TRCC cases were confirmed by In this study, we report the incidence and describe the another bioinformatic pipeline called FusionSeq (22). MITF/TFE genomic profile of translocations of the family
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Epigenome-Wide Exploratory Study of Monozygotic Twins Suggests Differentially Methylated Regions to Associate with Hand Grip Strength
    Biogerontology (2019) 20:627–647 https://doi.org/10.1007/s10522-019-09818-1 (0123456789().,-volV)( 0123456789().,-volV) RESEARCH ARTICLE Epigenome-wide exploratory study of monozygotic twins suggests differentially methylated regions to associate with hand grip strength Mette Soerensen . Weilong Li . Birgit Debrabant . Marianne Nygaard . Jonas Mengel-From . Morten Frost . Kaare Christensen . Lene Christiansen . Qihua Tan Received: 15 April 2019 / Accepted: 24 June 2019 / Published online: 28 June 2019 Ó The Author(s) 2019 Abstract Hand grip strength is a measure of mus- significant CpG sites or pathways were found, how- cular strength and is used to study age-related loss of ever two of the suggestive top CpG sites were mapped physical capacity. In order to explore the biological to the COL6A1 and CACNA1B genes, known to be mechanisms that influence hand grip strength varia- related to muscular dysfunction. By investigating tion, an epigenome-wide association study (EWAS) of genomic regions using the comb-p algorithm, several hand grip strength in 672 middle-aged and elderly differentially methylated regions in regulatory monozygotic twins (age 55–90 years) was performed, domains were identified as significantly associated to using both individual and twin pair level analyses, the hand grip strength, and pathway analyses of these latter controlling the influence of genetic variation. regions revealed significant pathways related to the Moreover, as measurements of hand grip strength immune system, autoimmune disorders, including performed over 8 years were available in the elderly diabetes type 1 and viral myocarditis, as well as twins (age 73–90 at intake), a longitudinal EWAS was negative regulation of cell differentiation.
    [Show full text]
  • Cloning of an Alpha-TFEB Fusion in Renal Tumors Harboring the T(6;11)(P21;Q13) Chromosome Translocation
    Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation Ian J. Davis*†, Bae-Li Hsi‡, Jason D. Arroyo*, Sara O. Vargas§, Y. Albert Yeh§, Gabriela Motyckova*, Patricia Valencia*, Antonio R. Perez-Atayde§, Pedram Argani¶, Marc Ladanyiʈ, Jonathan A. Fletcher*‡, and David E. Fisher*†** *Department of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Departments of †Medicine and §Pathology, Children’s Hospital Boston, Boston, MA 02115; ‡Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115; ʈDepartment of Pathology, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; and ¶Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21287 Communicated by Phillip A. Sharp, Massachusetts Institute of Technology, Cambridge, MA, March 12, 2003 (received for review January 28, 2003) MITF, TFE3, TFEB, and TFEC comprise a transcription factor family Among members of the MiT family, TFE3 has previously been (MiT) that regulates key developmental pathways in several cell implicated in cancer-associated translocations. TFE3 transloca- lineages. Like MYC, MiT members are basic helix-loop-helix-leucine tions occur in distinctive renal carcinomas of childhood and zipper transcription factors. MiT members share virtually perfect young adults and in alveolar soft part sarcoma. In these trans- homology in their DNA binding domains and bind a common DNA locations, the DNA binding domain of TFE3 is fused to various motif. Translocations of TFE3 occur in specific subsets of human N-terminal partners, including PRCC, NonO (p54nrb), PSF, or renal cell carcinomas and in alveolar soft part sarcomas. Although ASPL (15–20). Although the mechanism through which these multiple translocation partners are fused to TFE3, each transloca- fusions contribute to oncogenesis remains unclear, several stud- tion product retains TFE3’s basic helix–loop–helix leucine zipper.
    [Show full text]
  • Ancient Genomic Regulatory Blocks Are a Major Source for Gene Deserts in Vertebrates After Whole Genome Duplications
    Supplementary Information for: Ancient genomic regulatory blocks are a major source for gene deserts in vertebrates after whole genome duplications María Touceda-Suárez, Elizabeth M. Kita, Rafael D. Acemel, Panos N. Firbas, Marta S. Magri, Silvia Naranjo, Juan J. Tena, Jose Luis Gómez-Skarmeta, Ignacio Maeso, Manuel Irimia Corresponding Authors: Manuel Irimia Centre for Genomic Regulation Dr. Aiguader, 88, 08003 Barcelona, Spain e-mail: [email protected] Phone: +34933160212 Fax: +34933160099 Ignacio Maeso Centro Andaluz de Biología del Desarrollo (CABD-CSIC-UPO) Universidad Pablo de Olavide, Crta. Utrera km.1, 41013 Sevilla, España e-mail: [email protected] Phone: +34954348948 Fax: +34954349376 José Luis Gómez-Skarmeta Centro Andaluz de Biología del Desarrollo (CABD-CSIC-UPO) Universidad Pablo de Olavide, Crta. Utrera km.1, 41013 Sevilla, España e-mail: [email protected] Phone: +34954348948 Fax: +34954349376 1 Supplementary Figures Supplementary Figure S1 - Microsyntenic arrangements of ancient multi-bystander GRBs whose bystanders have become differentially retained next to different trans-dev ohnologs. For each case, the arrangement in a slow-evolving deuterostome (Bla, B. lanceolatum; Sko, S. kowalevskii; Spu, S. purpuratus) is provided on top (blue lines), followed by the GRB arrangements conserved in the human genome. 2 Supplementary Figure S2 - Evolution of the Hey-MrpS28-Hdcc2 GRB and its functional characterization in zebrafish. A) Phylogenetic distribution of the GRB across the studied metazoan species. Only B. floridae, S. kowalevskii, C. teleta and T. adhaerens have conserved both bystander genes: Hddc2 (grey) and MrpS28 (white), linked to the trans-dev gene Hey (black arrows). In vertebrates, each of the Hey paralogs has preserved only one of the bystander genes in a reciprocal manner.
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • 3D Cell Culture-Based Global Mirna Expression Analysis Reveals Mir-142-5P As a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment
    biomolecules Article 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment 1,2, 1,3, , 1,4,5 1 Linas Kunigenas y, Vaidotas Stankevicius * y, Audrius Dulskas , Elzbieta Budginaite , Gediminas Alzbutas 6,7, Eugenijus Stratilatovas 1,4, Nils Cordes 8,9,10,11,12 and Kestutis Suziedelis 1,2,* 1 National Cancer Institute, LT-08660 Vilnius, Lithuania; [email protected] (L.K.); [email protected] (A.D.); [email protected] (E.B.); [email protected] (E.S.) 2 Life Sciences Center, Institute of Biosciences, Vilnius University, LT-08412 Vilnius, Lithuania 3 Life Sciences Center, Institute of Biotechnology, Vilnius University, LT-08412 Vilnius, Lithuania 4 Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-08406 Vilnius, Lithuania 5 University of Applied Sciences, Faculty of Health Care, LT-08303 Vilnius, Lithuania 6 Thermo Fisher Scientific, LT-02241 Vilnius, Lithuania; gediminas.alzbutas@thermofisher.com 7 Institute of Informatics, Faculty of Mathematics and Informatics, Vilnius University,LT-08303 Vilnius, Lithuania 8 OncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine, Technische Universität, D–01307 Dresden, Germany; [email protected] 9 Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität, D–01307 Dresden, Germany 10 Helmholtz–Zentrum Dresden–Rossendorf, Institute of Radiooncology–OncoRay,D–01328 Dresden, Germany 11 German Cancer Consortium (DKTK), partner site Dresden, D–69192 Heidelberg, Germany 12 German Cancer Research Center (DKFZ), D–69192 Heidelberg, Germany * Correspondence: [email protected] (V.S.); [email protected] (K.S.); Tel.: +370-5219-0904 (K.S.) These authors contributed equally to the work.
    [Show full text]
  • SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons
    7980 • The Journal of Neuroscience, October 7, 2020 • 40(41):7980–7994 Neurobiology of Disease SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons Nerea Llamosas,1 Vineet Arora,1 Ridhima Vij,2,3 Murat Kilinc,1 Lukasz Bijoch,4 Camilo Rojas,1 Adrian Reich,5 BanuPriya Sridharan,6 Erik Willems,7 David R. Piper,7 Louis Scampavia,6 Timothy P. Spicer,6 Courtney A. Miller,1,6 J. Lloyd Holder,2,3 and Gavin Rumbaugh1 1Department of Neuroscience, Scripps Research, Jupiter, Florida 33458, 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas 77030, 3Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, 4Laboratory of Neurobiology, BRAINCITY, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland, 5Center for Computational Biology and Bioinformatics, Scripps Research, Jupiter, Florida 33458, 6Department of Molecular Medicine, Scripps Research, Jupiter, Florida 33458, and 7Cell Biology, Thermo Fisher Scientific, Carlsbad, California 92008 SYNGAP1 is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. De novo loss-of-function variants in this gene cause a neurodevelopmental disorder defined by cognitive impairment, social-communica- tion disorder, and early-onset seizures. Cell biological studies in mouse and rat neurons have shown that Syngap1 regulates developing excitatory synapse structure and function, with loss-of-function variants driving formation of larger dendritic spines and stronger glu- tamatergic transmission. However, studies to date have been limited to mouse and rat neurons. Therefore, it remains unknown how SYNGAP1 loss of function impacts the development and function of human neurons.
    [Show full text]
  • Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HD Mice
    Journal of Huntington’s Disease 5 (2016) 249–260 249 DOI 10.3233/JHD-160211 IOS Press Research Report Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice Petr Vodickaa, Kathryn Chaseb, Maria Iulianoa, Adelaide Tousleya, Dana T. Valentinea, Ellen Sappa, Kimberly B. Kegel-Gleasona, Miguel Sena-Estevesc, Neil Aroninb and Marian DiFigliaa,∗ aDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA bDepartments of Medicine and Cell Biology, University of Massachusetts, Worcester, MA, USA cDepartment of Neurology, Horae Gene Therapy Center, University of Massachusetts Medical School, Albert Sherman Center, Worcester, MA, USA Abstract. Background: Mutant huntingtin (mHTT) is encoded by the Huntington’s disease (HD) gene and its accumulation in the brain contributes to HD pathogenesis. Reducing mHTT levels through activation of the autophagosome-lysosomal pathway may have therapeutic benefit. Transcription factor EB (TFEB) regulates lysosome biogenesis and autophagy. Objective: To examine if increasing TFEB protein levels in HD mouse striatum induces autophagy and influences mHTT levels. Methods: We introduced cDNA encoding TFEB with an HA tag (TFEB-HA) under the control of neuron specific synapsin 1 promoter into the striatum of 3 month old HDQ175/Q7 mice using adeno-associated virus AAV2/9. The levels of exogenous TFEB were analyzed using qPCR and Western blot. Proteins involved in autophagy, levels of huntingtin, and striatal-enriched proteins were examined using biochemical and/or immunohistochemical methods. Results: In HD mice expressing TFEB-HA, HA immunoreactivity distributed throughout the striatum in neuronal cell bodies and processes and preferentially in neuronal nuclei and overlapped with a loss of DARPP32 immunoreactivity.
    [Show full text]
  • Genomic Landscape of Paediatric Adrenocortical Tumours
    ARTICLE Received 5 Aug 2014 | Accepted 16 Jan 2015 | Published 6 Mar 2015 DOI: 10.1038/ncomms7302 Genomic landscape of paediatric adrenocortical tumours Emilia M. Pinto1,*, Xiang Chen2,*, John Easton2, David Finkelstein2, Zhifa Liu3, Stanley Pounds3, Carlos Rodriguez-Galindo4, Troy C. Lund5, Elaine R. Mardis6,7,8, Richard K. Wilson6,7,9, Kristy Boggs2, Donald Yergeau2, Jinjun Cheng2, Heather L. Mulder2, Jayanthi Manne2, Jesse Jenkins10, Maria J. Mastellaro11, Bonald C. Figueiredo12, Michael A. Dyer13, Alberto Pappo14, Jinghui Zhang2, James R. Downing10, Raul C. Ribeiro14,* & Gerard P. Zambetti1,* Paediatric adrenocortical carcinoma is a rare malignancy with poor prognosis. Here we analyse 37 adrenocortical tumours (ACTs) by whole-genome, whole-exome and/or transcriptome sequencing. Most cases (91%) show loss of heterozygosity (LOH) of chromosome 11p, with uniform selection against the maternal chromosome. IGF2 on chromosome 11p is overexpressed in 100% of the tumours. TP53 mutations and chromosome 17 LOH with selection against wild-type TP53 are observed in 28 ACTs (76%). Chromosomes 11p and 17 undergo copy-neutral LOH early during tumorigenesis, suggesting tumour-driver events. Additional genetic alterations include recurrent somatic mutations in ATRX and CTNNB1 and integration of human herpesvirus-6 in chromosome 11p. A dismal outcome is predicted by concomitant TP53 and ATRX mutations and associated genomic abnormalities, including massive structural variations and frequent background mutations. Collectively, these findings demonstrate the nature, timing and potential prognostic significance of key genetic alterations in paediatric ACT and outline a hypothetical model of paediatric adrenocortical tumorigenesis. 1 Department of Biochemistry, St Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA. 2 Department of Computational Biology and Bioinformatics, St Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information Flow
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • MITF: Master Regulator of Melanocyte Development and Melanoma Oncogene
    Review TRENDS in Molecular Medicine Vol.12 No.9 MITF: master regulator of melanocyte development and melanoma oncogene Carmit Levy, Mehdi Khaled and David E. Fisher Melanoma Program and Department of Pediatric Hematology and Oncology, Dana-Farber Cancer Institute, Children’s Hospital Boston, 44 Binney Street, Boston, MA 02115, USA Microphthalmia-associated transcription factor (MITF) between MITF and TFE3 in the development of the acts as a master regulator of melanocyte development, osteoclast lineage [8]. From these analyses, it seems that function and survival by modulating various differentia- MITF is the only MiT family member that is functionally tion and cell-cycle progression genes. It has been essential for normal melanocytic development. demonstrated that MITF is an amplified oncogene in a MITF is thought to mediate significant differentiation fraction of human melanomas and that it also has an effects of the a-melanocyte-stimulating hormone (a-MSH) oncogenic role in human clear cell sarcoma. However, [9,10] by transcriptionally regulating enzymes that are MITF also modulates the state of melanocyte differentia- essential for melanin production in differentiated melano- tion. Several closely related transcription factors also cytes [11]. Although these data implicate MITF in both the function as translocated oncogenes in various human survival and differentiation of melanocytes, little is known malignancies. These data place MITF between instruct- about the biochemical regulatory pathways that control ing melanocytes towards terminal differentiation and/or MITF in its different roles. pigmentation and, alternatively, promoting malignant behavior. In this review, we survey the roles of MITF as a Transcriptional and post-translational MITF regulation master lineage regulator in melanocyte development The MITF gene has a multi-promoter organization in and its emerging activities in malignancy.
    [Show full text]
  • Mtor-Dependent Phosphorylation Controls TFEB Nuclear Export
    bioRxiv preprint doi: https://doi.org/10.1101/339416; this version posted June 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. mTOR-dependent phosphorylation controls TFEB nuclear export Gennaro Napolitano1,2, Alessandra Esposito1, Heejun Choi3, Valerio Benedetti1, Maria Matarese1, Chiara Di Malta1, Jlenia Monfregola1, Diego Luis Medina1, Jennifer Lippincott-Schwartz3,4 and Andrea Ballabio1,2,5,* 1Telethon Institute of Genetics and Medicine (TIGEM), Via Campi Flegrei 34, 80078 Pozzuoli, Naples, Italy. 2Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Via Pansini 5, 80131 Naples, Italy. 3Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, VA 20147, USA. 4National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD 20892, USA. 5Department of Molecular and Human Genetics and Neurological Research Institute, Baylor College of Medicine, Houston, TX 77030, USA. *Correspondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/339416; this version posted June 5, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The transcriptional activation of catabolic processes during starvation is induced by the nuclear translocation and consequent activation of transcription factor EB (TFEB), a master modulator of autophagy and lysosomal biogenesis. However, how TFEB is inactivated upon nutrient re-feeding is currently unknown. Here we show that TFEB subcellular localization is dynamically controlled by its continuous shuttling between the cytosol and the nucleus, with the nuclear export representing a limiting step.
    [Show full text]